View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Retina/Vitreous News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 14, 2024
4 min watch
Save

VIDEO: ANXV may improve vision in retinal vein occlusion

VIDEO: ANXV may improve vision in retinal vein occlusion

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Michael Singer, MD, discusses a phase 2a study on ANXV in treatment-naive patients with retinal vein occlusion.

SPONSORED CONTENT
June 13, 2024
1 min watch
Save

VIDEO: Data show positive effect of Axpaxli for wet AMD at 36 weeks

VIDEO: Data show positive effect of Axpaxli for wet AMD at 36 weeks

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Anat Loewenstein, MD, of Tel Aviv Medical Center in Israel, discusses Axpaxli for the treatment of neovascular age-related macular degeneration.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
June 12, 2024
2 min read
Save

Gene editing therapy shows potential for CEP290-associated inherited retinal degeneration

Gene editing therapy shows potential for <i>CEP290</i>-associated inherited retinal degeneration

A gene editing therapy showed safety and improvement in cone photoreceptor function in patients with CEP290-associated inherited retinal degeneration due to an IVS26 variant, according to a phase 1/2 study.

SPONSORED CONTENT
June 12, 2024
2 min read
Save

Supplementation with lutein from marigolds increases serum concentration

Supplementation with lutein from marigolds increases serum concentration

Daily supplementation of lutein via marigold extract increases serum concentration to levels associated with a lower risk of developing age-related eye disease, according to study results published in Nutrients.

SPONSORED CONTENT
June 12, 2024
2 min watch
Save

VIDEO: COAST, ShORe trials aim to replicate superiority demonstrated in phase 2b trial

VIDEO: COAST, ShORe trials aim to replicate superiority demonstrated in phase 2b trial

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Fred Guerard, CEO of Opthea, shares updates on the COAST and ShORe trials.

SPONSORED CONTENT
June 12, 2024
1 min watch
Save

VIDEO: Better understanding of Bruch’s membrane may help development of AMD treatments

VIDEO: Better understanding of Bruch&rsquo;s membrane may help development of AMD treatments

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, discusses how targeting abnormalities in Bruch’s membrane in patients with age-related macular degeneration may aid in the development of treatments.

SPONSORED CONTENT
June 11, 2024
3 min watch
Save

VIDEO: Real-world data explore treatment extension for aflibercept 8 mg

VIDEO: Real-world data explore treatment extension for aflibercept 8 mg

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, David A. Eichenbaum, MD, presents real-world data related to the use of aflibercept 8 mg.

SPONSORED CONTENT
June 10, 2024
1 min watch
Save

VIDEO: Pegcetacoplan reduces number of scotomatous points at 36 months

VIDEO: Pegcetacoplan reduces number of scotomatous points at 36 months

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Dilsher S. Dhoot, MD, discusses the functional benefits of pegcetacoplan in patients with geographic atrophy.

SPONSORED CONTENT
June 10, 2024
2 min watch
Save

VIDEO: Anti-VEGF biosimilars may offer cost savings, accessibility for AMD treatment

VIDEO: Anti-VEGF biosimilars may offer cost savings, accessibility for AMD treatment

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses an update on the use of anti-VEGF biosimilars for the treatment of age-related macular degeneration.

SPONSORED CONTENT
June 09, 2024
6 min watch
Save

VIDEO: Patients with severe DME benefit from high-dose aflibercept

VIDEO: Patients with severe DME benefit from high-dose aflibercept

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Deepak Sambhara, MD, discusses central retinal thickness in patients with diabetic macular edema.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails